Clinical trial
A Study of DA-8159 in Subjects With Erectile Dysfunction
NCT00282607 · Dong-A PharmTech Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00282607 |
|---|---|
| Title | A Study of DA-8159 in Subjects With Erectile Dysfunction |
| Official title | A Randomized, Placebo-Controlled, Double-Blind, Parallel Design Phase 2 Dose Ranging Trial To Assess The Safety and Efficacy of DA-8159 Tablets in Male Subjects With Erectile Dysfunction. |
| Lead sponsor | Dong-A PharmTech Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Erectile Dysfunction |
| Intervention type | Drug |
| Interventions | DA-8159 |
| Enrollment | 300 |
| Start date | May 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Jan 27, 2006 |
| Last update posted | Feb 28, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: